These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32811216)

  • 1. Soluble endoglin in urine as an early-pregnancy preeclampsia marker: antenatal longitudinal feasibility study.
    Nogueira Reis ZS; Pereira JB; Costa LAC; Barra JS
    J Obstet Gynaecol; 2021 Jul; 41(5):693-698. PubMed ID: 32811216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.
    Stepan H; Geipel A; Schwarz F; Krämer T; Wessel N; Faber R
    Am J Obstet Gynecol; 2008 Feb; 198(2):175.e1-6. PubMed ID: 18226617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis values of serum STAT4 and sEng in preeclampsia.
    Zhang L; Li X; Zhou C; You Z; Zhang J; Cao G
    J Clin Lab Anal; 2020 Feb; 34(2):e23073. PubMed ID: 31628681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes.
    Holmes VA; Young IS; Patterson CC; Maresh MJ; Pearson DW; Walker JD; McCance DR;
    Diabetes Care; 2013 Nov; 36(11):3671-7. PubMed ID: 23920083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
    Leaños-Miranda A; Navarro-Romero CS; Sillas-Pardo LJ; Ramírez-Valenzuela KL; Isordia-Salas I; Jiménez-Trejo LM
    Hypertension; 2019 Oct; 74(4):991-997. PubMed ID: 31446801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
    Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the usefulness of endoglin level as a predictor of preeclampsia in pregnant women with hypertension].
    Głuchowska M; Kowalska-Koprek U; Karowicz-Bilińska A
    Ginekol Pol; 2013 Oct; 84(10):835-40. PubMed ID: 24273904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
    Powers RW; Jeyabalan A; Clifton RG; Van Dorsten P; Hauth JC; Klebanoff MA; Lindheimer MD; Sibai B; Landon M; Miodovnik M;
    PLoS One; 2010 Oct; 5(10):e13263. PubMed ID: 20948996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?
    Myatt L; Clifton RG; Roberts JM; Spong CY; Wapner RJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Sciscione A; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
    BJOG; 2013 Sep; 120(10):1183-91. PubMed ID: 23331974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia.
    Martinez-Fierro ML; Castruita-De La Rosa C; Garza-Veloz I; Cardiel-Hernandez RM; Espinoza-Juarez MA; Delgado-Enciso I; Castañeda-Lopez ME; Cardenas-Vargas E; Trejo-Vázquez F; Sotelo-Ham EI; Castañeda-Miranda R; Cid-Baez MA; Ortiz-Rodriguez JM; Solis-Sanchez LO; Aviles AG; Ortiz-Castro Y
    Hypertens Pregnancy; 2018 Feb; 37(1):37-50. PubMed ID: 29308696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction].
    Zhang LJ; Han YH; Han YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):371-4. PubMed ID: 20594474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
    Rana S; Karumanchi SA; Levine RJ; Venkatesha S; Rauh-Hain JA; Tamez H; Thadhani R
    Hypertension; 2007 Jul; 50(1):137-42. PubMed ID: 17515455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia.
    Schmella MJ; Assibey-Mensah V; Parks WT; Roberts JM; Jeyabalan A; Hubel CA; Catov JM
    Placenta; 2019 Mar; 78():29-35. PubMed ID: 30955708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy.
    Liu M; Luo X; Xu Q; Yu H; Gao L; Zhou R; Wang T
    Front Immunol; 2021; 12():702385. PubMed ID: 34671343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
    Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes.
    Christiansen MS; Hesse D; Ekbom P; Hesse U; Damm P; Hommel E; Feldt-Rasmussen B; Mathiesen E
    Diabetes Res Clin Pract; 2010 Jul; 89(1):16-21. PubMed ID: 20392509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus.
    Kapustin RV; Kopteeva EV; Alekseenkova EN; Korenevsky AV; Smirnov IV; Arzhanova ON
    Hypertens Pregnancy; 2022; 41(3-4):173-180. PubMed ID: 35475412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.